In summary, our study indicated that KCNQ1OT1 promotes drug resistance of AEDs in vitro through targeting the miR-138-5p/NF-κB/ABCB1 axis, providing a potential target for overcoming drug resistance in epilepsy. This evidence concerns the gene KCNQ1OT1 and epilepsy.